Vimarsana
Biggest News Aggregation in the World

Page 5 - Hambrecht Quist News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hambrecht Quist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hambrecht Quist Today - Breaking & Trending Today

Anya Hindmarch CBE, Danny Rimer OBE, Howard Shore, Kwame Kwei-Armah OBE and Lord Ed Vaizey have been appointed as Trustees of the Tate - Vimarsana News

Anya Hindmarch CBE, Danny Rimer OBE, Howard Shore, Kwame Kwei-Armah OBE and Lord Ed Vaizey have been appointed as Trustees of the Tate

The Prime Minister has appointed Anya Hindmarch CBE, Danny Rimer OBE, Howard Shore, Kwame Kwei-Armah OBE and Howard Shore as Trustees of the Tate for four year terms, from 7 January 2022 until 6 January 2026.

Source: gov.uk
BioNTech (NASDAQ:BNTX) and Illumina (NASDAQ:ILMN): 10x Returns to Investors - Vimarsana News

BioNTech (NASDAQ:BNTX) and Illumina (NASDAQ:ILMN): 10x Returns to Investors

The equity analysts that correctly identified BioNTech (NASDAQ:BNTX)  and Illumina (ILMN) for investors deserve a closer look.

Source: twst.com
Phillips to offer property from the collection of California philanthropist Robin Quist Gates - Vimarsana News

Phillips to offer property from the collection of California philanthropist Robin Quist Gates

a href= http://www.phillips.com target= _blank Phillips /a announced the sale of property from the estate Robin Quist Gates, the Northern Californ

Sierra Oncology Welcomes Two New Independent Directors to its Board - Vimarsana News

Sierra Oncology Welcomes Two New Independent Directors to its Board

/PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer,...

Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors - Vimarsana News

Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors

/PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the appointment of...